Team Handball Boosts Health in Inactive Middle-Aged and Older Men
A completed trial tests how often recreational handball must be played to drive meaningful cardiovascular and fitness gains in older inactive men.
Summary
This completed clinical trial enrolled 68 inactive middle-aged and older men in a recreational team handball programme to determine how training frequency affects health outcomes. Researchers from the University Institute of Maia examined dose-response relationships across cardiovascular, metabolic, musculoskeletal, and physical fitness markers in participants with no prior handball experience. The trial ran from late 2017 through mid-2019 and hypothesized that higher weekly training frequency would produce greater improvements. Team sports offer a socially engaging alternative to traditional exercise prescriptions, which is especially relevant for men who struggle to maintain solo gym routines. Results from this trial could help clinicians and public health professionals design minimum-effective-dose exercise programmes for aging populations who are currently sedentary.
Detailed Summary
Finding exercise formats that inactive older men will actually sustain is one of the central challenges in preventive medicine and healthy aging. Traditional gym-based programmes often suffer from poor long-term adherence, making team sports an attractive alternative that combines physical demand with social motivation.
This completed clinical trial, sponsored by the University Institute of Maia, enrolled 68 inactive middle-aged and older men with no prior team handball experience. The intervention was a structured recreational handball programme, and the primary scientific question was dose-response: how does weekly training frequency influence improvements in cardiovascular, metabolic, musculoskeletal, and physical fitness outcomes?
The trial ran from December 2017 to July 2019. Researchers hypothesized that greater weekly training frequency would produce proportionally larger health gains. By examining multiple health domains simultaneously, the study aimed to build a comprehensive picture of how a novel team sport affects aging men across a range of physiological systems rather than focusing on a single biomarker.
While the full results have not been published in the available abstract, the design is well-suited to generate actionable dose-response data. If higher frequency training produced significantly better outcomes, clinicians could use that threshold to set minimum prescription targets. If lower-frequency programmes proved sufficient, that finding would support accessible entry points for the most sedentary individuals.
The study's implications extend to public health and clinical practice, particularly for primary care physicians and exercise physiologists working with sedentary aging men. Team handball is an underutilized exercise modality in English-speaking countries but is widely played in Europe and could be adapted globally. Caveats include the all-male sample, the absence of a control group description in the abstract, and the fact that full outcome data are not yet available in peer-reviewed form.
Key Findings
- Recreational team handball was tested as a structured exercise prescription for inactive middle-aged and older men.
- The trial examined dose-response effects across cardiovascular, metabolic, musculoskeletal, and fitness markers.
- Higher weekly training frequency was hypothesized to produce greater health improvements.
- 68 men with zero prior handball experience completed the multi-year programme.
- Results may define minimum effective training doses for sedentary aging men.
Methodology
This was a completed interventional trial (Phase NA) enrolling 68 inactive middle-aged and older men in a recreational team handball programme. The design examined dose-response effects by varying weekly training frequency across participants. The trial ran approximately 19 months, from December 2017 to July 2019, at the University Institute of Maia.
Study Limitations
This summary is based on the abstract only, as the full study results are not publicly available; specific outcome data and statistical findings cannot be reported. The sample is exclusively male, limiting generalizability to women. No control group structure or blinding procedures are described in the available abstract.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: